StreetInsider.com News Articles

Form DEFA14A RADNOSTIX INC

Thu, 04 Jun 2026 13:08:00 -0400

si-local-file:///var/storage/secattach/20260604/26604644.html

Form DEFA14A RADNOSTIX INC

Thu, 04 Jun 2026 13:08:00 -0400

si-local-file:///var/storage/secattach/20260604/26604644.html

Form DEF 14A RADNOSTIX INC For: Jul 16

Thu, 04 Jun 2026 12:39:00 -0400

si-local-file:///var/storage/secattach/20260604/26604533.html

Form DEF 14A RADNOSTIX INC For: Jul 16

Thu, 04 Jun 2026 12:39:00 -0400

si-local-file:///var/storage/secattach/20260604/26604533.html

Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown

Thu, 21 May 2026 11:05:00 -0400

IDAHO FALLS, Idaho, May 21, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a manufacturer of radioisotope-focused products for medical, industrial, and research applications, today announced its financial results for the first quarter ended March 31, 2026 and the filing of its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission.

First Quarter 2026 Financial and Operational Summary

Total revenue decreased 27% to $2.38 million from $3.24 million in the first quarter of 2025, driven by recall impacts,

Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown

Thu, 21 May 2026 11:05:00 -0400

First Quarter 2026 Financial and Operational Summary

Total revenue decreased 27% to $2.38 million from $3.24 million in the first quarter of 2025, driven by recall impacts,

Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown

Thu, 21 May 2026 11:05:00 -0400

First Quarter 2026 Financial and Operational Summary

Total revenue decreased 27% to $2.38 million from $3.24 million in the first quarter of 2025, driven by recall impacts,

Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown

Thu, 21 May 2026 11:05:00 -0400

First Quarter 2026 Financial and Operational Summary

Total revenue decreased 27% to $2.38 million from $3.24 million in the first quarter of 2025, driven by recall impacts,

Form 8-K RADNOSTIX INC For: May 14

Wed, 20 May 2026 15:37:00 -0400

si-local-file:///var/storage/secattach/20260520/26527933.html

Form 8-K RADNOSTIX INC For: May 14

Wed, 20 May 2026 15:37:00 -0400

si-local-file:///var/storage/secattach/20260520/26527933.html

Form 10-Q RADNOSTIX INC For: Mar 31

Wed, 20 May 2026 14:36:00 -0400

si-local-file:///var/storage/secattach/20260520/26527616.html

Form 10-Q RADNOSTIX INC For: Mar 31

Wed, 20 May 2026 14:36:00 -0400

si-local-file:///var/storage/secattach/20260520/26527616.html

Form NT 10-Q RADNOSTIX INC For: Mar 31

Fri, 15 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260515/26506513.html

Form NT 10-Q RADNOSTIX INC For: Mar 31

Fri, 15 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260515/26506513.html

Form SCHEDULE 13G RADNOSTIX INC Filed by: Kennerman Associates, Inc.

Thu, 14 May 2026 16:53:00 -0400

si-local-file:///var/storage/secattach/20260514/26496217.html

Form SCHEDULE 13G RADNOSTIX INC Filed by: Kennerman Associates, Inc.

Thu, 14 May 2026 16:53:00 -0400

si-local-file:///var/storage/secattach/20260514/26496217.html

Form 4 RADNOSTIX INC For: Feb 17 Filed by: GROSSO CHRISTOPHER G

Thu, 30 Apr 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260430/26410352.html

Form 4 RADNOSTIX INC For: Feb 17 Filed by: GROSSO CHRISTOPHER G

Thu, 30 Apr 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260430/26410352.html

Form 10-K/A RADNOSTIX INC For: Dec 31

Thu, 30 Apr 2026 14:54:00 -0400

si-local-file:///var/storage/secattach/20260430/26406327.html

Form 10-K/A RADNOSTIX INC For: Dec 31

Thu, 30 Apr 2026 14:54:00 -0400

si-local-file:///var/storage/secattach/20260430/26406327.html

Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025

Wed, 01 Apr 2026 11:05:00 -0400

IDAHO FALLS, Idaho, April 1, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a leading manufacturer of radioisotope-focused technologies for medical, industrial, and research applications, today announced its fiscal year 2025 financial results and corporate updates.

Fiscal 2025 Highlights

Total revenue reached $13.07 million, the second-highest annual revenue in Company history, reflecting healthy demand across core segments despite targeted supply chain challenges.
Calibration & Reference Products segment achieved record growth, with sales increasing 21% to $4.25 million, driven by new PET-focused products, expanded

Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025

Wed, 01 Apr 2026 11:05:00 -0400

Fiscal 2025 Highlights

Total revenue reached $13.07 million, the second-highest annual revenue in Company history, reflecting healthy demand across core segments despite targeted supply chain challenges.
Calibration & Reference Products segment achieved record growth, with sales increasing 21% to $4.25 million, driven by new PET-focused products, expanded

Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025

Wed, 01 Apr 2026 11:05:00 -0400

Fiscal 2025 Highlights

Total revenue reached $13.07 million, the second-highest annual revenue in Company history, reflecting healthy demand across core segments despite targeted supply chain challenges.
Calibration & Reference Products segment achieved record growth, with sales increasing 21% to $4.25 million, driven by new PET-focused products, expanded

Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025

Wed, 01 Apr 2026 11:05:00 -0400

Fiscal 2025 Highlights

Total revenue reached $13.07 million, the second-highest annual revenue in Company history, reflecting healthy demand across core segments despite targeted supply chain challenges.
Calibration & Reference Products segment achieved record growth, with sales increasing 21% to $4.25 million, driven by new PET-focused products, expanded

Form 10-K RADNOSTIX INC For: Dec 31

Tue, 31 Mar 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20260331/26251904.html